Although many studies have shown the release of IL-1α and IL-1β on AMI experimental models, the increase in IL-1 plasma levels in AMI patients was not systematically highlighted, some studies showing values ​​comparable to those of patients without coronary disease [14]. The gene discussed is IL1B; the disease is coronary artery disorder.